Synspira’s Therapy Candidate May Be a Game-Changer for Drug-Resistant Bacteria in CF
Chronic pulmonary infections are a hallmark of lung disease in patients with cystic fibrosis. Due to the variability in bacteria that can colonize the lung and the specific antibiotic treatments that may be effective, treatment strategies are often tailored to individual patients. But some bacterial infections are…